Skip to main content

Volume 18 Supplement 1

Proceedings from NextGen Therapies for SJIA & MAS – 2019


Publication of this supplement has been supported by the SJIA Foundation. The article has undergone the journal's standard peer review process for supplements. CS is the Editor-in-Chief of Pediatric Rheumatology. No other competing interests were declared.

Bethesda, MD, USA3-4 October 2019

Conference website

Edited by Charles Spencer.

  1. For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arth...

    Authors: Scott W. Canna, Grant S. Schulert, Adriana de Jesus, Alex Pickering, Hermine Brunner, Massimo Gadina, Stewart Levine, Raphaela Goldbach-Mansky, Jonathan Boutelle, Rashmi Sinha, Fabrizio DeBenedetti and Alexei Grom
    Citation: Pediatric Rheumatology 2020 18(Suppl 1):53

Official journal of

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.8
    5-year Journal Impact Factor: 2.8
    Source Normalized Impact per Paper (SNIP): 0.966
    SCImago Journal Rank (SJR): 0.835

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 94

    Usage 2023
    Downloads: 1,095,144
    Altmetric mentions: 691